CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a humanized antibody targeting cancer stem cells, which are crucial for tumor growth and treatment resistance. The goal is to advance this therapy towards clinical trials for glioblastoma multiforme, a challenging brain cancer.
Global cancer market is growing at a CAGR of 6.9% with an estimated value of $81bn in 2016.
Although the huge R&D investment observed in the past years in the development of new treatments, there is still lack on an effective treatment in many tumour types.
In particular, the median survival for glioblastoma multiforme (GBM), a high-grade brain tumour affecting 23,000 patients a year in US and EU, is 14 months and its 5-yr survival less than 5%.
It is therefore urgent to develop more effective t…
FUNDACION PRIVADA INSTITUTO DEINVESTIGACION ONCOLOGICA DE VALL-HE
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
